When should vitamin K be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin K Administration Guidelines

Vitamin K should be administered to all newborns at birth, with intramuscular injection being the preferred route (1 mg vitamin K1), though oral regimens are acceptable alternatives in specific situations. 1, 2

Newborns and Infants

Healthy Term Newborns

  • Intramuscular (IM) route (preferred): 1 mg vitamin K1 as a single dose at birth 1, 2
  • Oral route alternatives (if IM not possible or refused):
    • Option 1: 3 × 2 mg vitamin K1 orally at birth, at 4-6 days, and at 4-6 weeks
    • Option 2: 2 mg vitamin K1 orally at birth, followed by weekly doses of 1 mg for 3 months 2

High-Risk Newborns

For infants with increased bleeding risk (premature, perinatal asphyxia, difficult delivery, delayed feeding, liver disease):

  • First dose must be administered via IM or slow IV route 3, 4
  • Subsequent doses should be individualized based on clinical status 4

Preterm and Term Infants on Parenteral Nutrition

  • 10 μg/kg/day of vitamin K for infants up to 12 months of age 1
  • Older children: 200 μg/day 1

Special Situations

Exclusively Breastfed Infants

  • Higher risk of vitamin K deficiency due to low concentrations in breast milk 3, 4
  • After initial prophylaxis, weekly oral administration of 2 mg (or 25 μg/day) vitamin K until completion of breastfeeding 4

Infants of Mothers on Medications Affecting Vitamin K

For mothers taking anticoagulants, anticonvulsants, or barbiturates:

  • Antenatal maternal prophylaxis: 10-20 mg/day orally for 15-30 days before delivery to prevent early VKDB 4
  • Newborns require special supplementation protocol according to local policy 1

Vitamin K for Warfarin Reversal

Non-Urgent Reversal (INR 5-9, No Significant Bleeding)

  • Omit next 1-2 doses of warfarin and give vitamin K1 1-2.5 mg orally 1
  • INR should fall within 24 hours 1

Urgent Reversal (INR >9, No Significant Bleeding)

  • Vitamin K1 3-5 mg orally 1
  • Monitor INR closely and repeat vitamin K as necessary 1

Emergency Reversal (Serious Bleeding or Major Overdose)

  • Vitamin K1 10 mg by slow IV infusion (over 30 minutes) 1, 5
  • Supplement with fresh plasma or prothrombin complex concentrate 1, 5
  • Additional doses of vitamin K1 may be needed every 12 hours 1

Monitoring

  • Classical coagulation tests can be used in low-risk infants for indirect evaluation of vitamin K status 1
  • Undercarboxylated Serum Vitamin K-Dependent Proteins (PIVKA-II) are useful biomarkers for subclinical deficiency in at-risk groups 1, 3

Important Considerations

  • Document date, dose, and mode of administration for all vitamin K prophylaxis 2
  • Record parental refusal after adequate information is provided due to risk of late VKDB 2
  • If an infant vomits within 1 hour of oral administration, repeat the dose 2
  • The oral route is not appropriate for preterm infants, those with cholestasis, impaired intestinal absorption, or those too unwell to take oral vitamin K1 2

Cautions

  • A single dose of 0.2 mg IM vitamin K has been reported as insufficient to prevent late VKDB in exclusively breastfed infants 6
  • Vitamin K1 administered IV can rarely cause anaphylactoid reactions with bronchospasm and cardiac arrest 1
  • Rapid reversal of warfarin with vitamin K may return patients to a prothrombotic state 5

The evidence strongly supports universal vitamin K prophylaxis for all newborns, with the intramuscular route being most reliable for preventing the potentially fatal vitamin K deficiency bleeding.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nutrition Monitoring in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.